Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 1,500 shares at $524.99 ($787K) on 2026-07-02, disclosed to the SEC on 2026-07-07.
Scheduled sale ($787k) by EVP, Chief Reg. & Quality Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |
| VRTX | SELL | 2026-01-09 | $2.1M | — | Filing → |